All terms in CHEBI
| Label | Id | Description |
|---|---|---|
| trans-10-heptadecenoic acid | CHEBI_75097 | [The trans-isomer of 10-heptadecenoic acid.] |
| 10-heptadecenoic acid | CHEBI_75098 | [A heptadecenoic acid having its double bond in the 10-position.] |
| heptadecenoic acid | CHEBI_36001 | [Any C17 straight-chain monounsaturated fatty acid having one C=C double bond.] |
| 10-heptadecenoate | CHEBI_133736 | [A monounsaturated fatty acid anion that is the conjugate base of 10-heptadecenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.] |
| 1-oleoyl-2-arachidonoyl-sn-glycero-3-phospho-L-serine | CHEBI_75099 | [A 3-sn-phosphatidyl-L-serine in which the phosphatidyl acyl groups at positions 1 and 2 are specified as oleoyl and arachidonoyl respectively.] |
| 1-oleoyl-2-arachidonoyl-sn-glycero-3-phospho-L-serine(1-) | CHEBI_74897 | [A phosphatidylserine 38:5 that is the conjugate base of 1-oleoyl-2-arachidonoyl-sn-glycero-3-phospho-L-serine, in which the carboxy and phosphate groups are anionic and the amino group is cationic.] |
| trans-10-pentadecenoic acid | CHEBI_75090 | [The trans-isomer of pentadec-10-enoic acid.] |
| aclacinomycin N | CHEBI_75091 | [An anthracycline antibiotic that is aclacinomycin A in which the keto group on the trisaccharide fragment has been reduced in a stereospecific manner to the corresponding alcohol.] |
| aclacinomycin N(1+) | CHEBI_74924 | [An anthracycline cation that is the conjugate acid of aclacinomycin N, obtained by protonation of the tertiary amino group.] |
| aclacinomycin N zwitterion | CHEBI_77991 | [A zwitterion obtained by transfer of a proton from the 5-hydroxy to the tertiary amino group of aclacinomycin N. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).] |
| aklavinone | CHEBI_31181 | |
| morin | CHEBI_75092 | [A pentahydroxyflavone that is 7-hydroxyflavonol bearing three additional hydroxy substituents at positions 2' 4' and 5.] |
| angiogenesis modulating agent | CHEBI_50926 | [An agent that modulates the physiologic angiogenesis process. This is accomplished by endogenous angiogenic proteins and a variety of other chemicals and pharmaceutical agents.] |
| aclacinomycin Y | CHEBI_75093 | [An anthracycline antibiotic that is aclacinomycin A in which the ketone function on the trisaccharide fragment has undergone 2,3-dehydrogenation to afford the corresponding enone.] |
| aclacinomycin Y(1+) | CHEBI_74929 | [An anthracycline cation that is the conjugate acid of aclacinomycin Y, obtained by protonation of the tertiary amino group.] |
| aclacinomycin Y zwitterion | CHEBI_77985 | [A zwitterion obtained by transfer of a proton from the 5-hydroxy to the tertiary amino group of aclacinomycin Y. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).] |
| (10Z)-heptadecenoic acid | CHEBI_75094 | [The cis-isomer of 10-heptadecenoic acid.] |
| (10Z)-heptadecenoate | CHEBI_78990 | [A monounsaturated fatty acid anion that is the conjugate base of (10Z)-heptadecenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.] |
| chrysin | CHEBI_75095 | [A dihydroxyflavone in which the two hydroxy groups are located at positions 5 and 7.] |
| EC 2.7.11.18 (myosin-light-chain kinase) inhibitor | CHEBI_78763 | [An EC 2.7.11.* (protein-serine/threonine kinase) inhibitor that interferes with the action of myosin-light-chain kinase (EC 2.7.11.18).] |